| scholarly article | Q13442814 |
| P50 | author | Janey Messina | Q58671834 |
| P2093 | author name string | Richard J Wenstrup | |
| Steven Tahan | |||
| Alexander Gutin | |||
| Loren E Clarke | |||
| Scott R Florell | |||
| Sancy Leachman | |||
| Anne-Renee Hartman | |||
| Christopher R Shea | |||
| Pedram Gerami | |||
| Jane Messina | |||
| Benjamin Roa | |||
| Darl D Flake | |||
| Kathryn A Kolquist | |||
| Kristen Rushton | |||
| Colleen Rock | |||
| Kirstin M Roundy | |||
| Steven Billings | |||
| M B Warf | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor | Q28304420 | ||
| The gene expression signatures of melanoma progression | Q30850724 | ||
| Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue | Q33415977 | ||
| Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome | Q33638348 | ||
| Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic | Q34645957 | ||
| Noninvasive genomic detection of melanoma | Q35054449 | ||
| S100A8 and S100A9: new insights into their roles in malignancy | Q35649454 | ||
| Classifying Melanocytic Tumors Based on DNA Copy Number Changes | Q35843508 | ||
| Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool | Q36365473 | ||
| Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center | Q37715229 | ||
| Nevus versus melanoma: to FISH, or not to FISH. | Q37864895 | ||
| What's new in prognostication of melanoma in the dermatopathology laboratory? | Q38100893 | ||
| Altered molecular pathways in melanocytic lesions. | Q38508830 | ||
| Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas | Q40357633 | ||
| Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists | Q41006635 | ||
| Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up | Q43550830 | ||
| Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma | Q46115773 | ||
| Novel genes associated with malignant melanoma but not benign melanocytic lesions | Q46226262 | ||
| False discovery rate, sensitivity and sample size for microarray studies. | Q47384576 | ||
| Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. | Q50447893 | ||
| Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. | Q50954469 | ||
| Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation. | Q53124327 | ||
| Identification of new genes associated with melanoma. | Q54603816 | ||
| An immune-active tumor microenvironment favors clinical response to ipilimumab | Q56898024 | ||
| Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party | Q73828588 | ||
| The vanishing biopsy: the trend toward smaller specimens | Q82303196 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 244-252 | |
| P577 | publication date | 2015-04-13 | |
| P1433 | published in | Journal of Cutaneous Pathology | Q15749389 |
| P1476 | title | Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma | |
| P478 | volume | 42 |
| Q38814312 | A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment |
| Q37663934 | An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi |
| Q47193617 | Association of Clinical, Dermoscopic, and Histopathologic Findings With Gene Expression in Patients With Balloon Cell Melanoma |
| Q50068785 | Atypical Melanocytic Proliferations: A Review of the Literature |
| Q90311353 | Common Nevus and Skin Cutaneous Melanoma: Prognostic Genes Identified by Gene Co-Expression Network Analysis |
| Q39770077 | Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. |
| Q89326715 | Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms |
| Q41066052 | Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma |
| Q90355640 | Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis |
| Q51795679 | Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model. |
| Q50135801 | New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance |
| Q36658116 | PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma |
| Q59591338 | RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas |
| Q26740631 | Recent advances in molecular genetics of melanoma progression: implications for diagnosis and treatment |
| Q91148596 | Reply to Reimann et al |
| Q58747488 | Review of diagnostic, prognostic, and predictive biomarkers in melanoma |
| Q52836510 | Significance of epidermal mitoses in challenging melanocytic proliferations. |
| Q51113981 | Testing of viable human skin cell dilution cultures as an approach to validating microsampling. |
| Q37328816 | The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists |
| Q41067550 | The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions |
| Q89748146 | Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis |
| Q38818516 | Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy |
Search more.